Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million
Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million High-profile investors led by T. Rowe Price and Fidelity back a new...
Cleerly Named Fierce Medtech’s “Fierce 15” Med Tech Companies of 2021
Organization recognizes venture-backed competitive companies championing innovation and creativity. New York, March 7, 2022 -- Cleerly, the company...
Cleerly Takes Precision Heart Care to the Next Level With Cleerly 2.2.0
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease. New York, February 8, 2022 -- Cleerly, the company...
Cleerly Named to NYC Digital Health 100 by New York City Health Business Leaders
Organization recognizes the most promising and innovative health startups in New York. New York, February 2, 2022 -- Cleerly, the company creating a...
